Clinical Trial Update: This Study Tests How BI 655130 Works in Patients With Active Ulcerative Colitis. The Study Also Tests How Well BI 655130 is Tolerated and Whether it Helps the Patients [Phase 2]

View source ↗

Summary

This Boehringer Ingelheim Phase 2 study assessed BI 655130 in active ulcerative colitis, evaluating safety, tolerability, and potential efficacy with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• BI 655130

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Colitis, Ulcerative | Phase 2 | Status: COMPLETED | Results posted: 2020-11-16